Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Peer Intervention to Improve Access Among Rural Women Veterans With Psychological Distress and Unmet Social Needs (EMBER)

25 lipca 2022 zaktualizowane przez: Syracuse VA Medical Center

Use of a Peer Intervention to Improve Access Among Rural Women Veterans With Psychological Distress and Unmet Social Needs

This research project will refine and evaluate delivery of a peer-delivered evidence-based intervention to improve perceived access and actual engagement with mental health treatment and social resource service use among rural women Veterans, especially Veterans of color, with psychological distress and unmet social needs.

Przegląd badań

Status

Aktywny, nie rekrutujący

Warunki

Interwencja / Leczenie

Szczegółowy opis

Not only do rural women Veterans report significant psychological distress (PTSD, anxiety, depression, suicide risk) and social needs (housing, transportation, material insecurity), they also experience substantial barriers accessing services which limits the Veteran Health Administration's (VHA) ability to address their needs. Personalized Support for Progress (PSP) is a virtually delivered intervention in which a Peer Specialist supports Veterans in prioritizing their needs and attaining access to the Veterans' preferred services. This trial is investigating whether PSP with rural women Veterans is associated with improved perceived access and actual engagement to mental health and social resource services, as well as high satisfaction and improved mental health, social needs and function outcomes. Rural women Veterans of color are more likely to be coping with psychological distress and social needs, as well as experiencing barriers to engagement and retention in services. Therefore this trial is designed to ensure that PSP delivery is tailored to increase rural women Veterans of color's acceptability.

The primary study design is a randomized controlled trial of Tailored Referral Information (TR) compared to Personalized Support for Progress (PSP) intervention for rural women Veterans with psychological distress and social needs (Aim 2). Prior to implementing the trial, focus groups and individual interviews will be conducted with women Veterans, Peer Specialists, and providers/stakeholders to determine any needed adaptations to determine any needed adaptations of PSP delivery for rural women Veterans and for PSP implementation in rural primary care clinics (Aim 1).

Typ studiów

Interwencyjne

Zapisy (Oczekiwany)

72

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

  • Stany Zjednoczone
    • New York
      • Syracuse, New York, Stany Zjednoczone, 13210
        • Syracuse VA Medical Center
    • Texas
      • Houston, Texas, Stany Zjednoczone, 77030
        • Michael E. DeBakey VA Medical Center

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat i starsze (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Kobieta

Opis

Aim 1 (Focus groups and interviews with women Veterans, Peer Specialists, and Providers to assess adaptations needed for PSP prior to the intervention trial)

Inclusion Criteria:

Veteran Inclusion:

  • Veteran status (non-Veterans will not be enrolled in this trial)
  • Identifies as a woman or as gender fluid
  • Resides in a rural or highly rural area
  • Psychological distress in the past 6 months as evidenced by a diagnosis in the electronic health record or elevated score on the PHQ-9, GAD-7 and/or PCL
  • At least one social need in the past 6 months on the PRAPARE
  • Ability to communicate in English including reading, writing, hearing, and speaking well enough to complete research and intervention tasks.

Providers Inclusion Criteria:

• Any provider (physician, social worker, therapist, etc. with experience working with rural women Veterans) employed by the VHA

Peers inclusion criteria:

•Any peer specialist employed by the VHA who identifies as a woman or as gender fluid

Veteran Exclusion Criteria:

  • Any Veteran with high suicide or homicide risk and/or evaluated by the PI or another clinician to be clinically unstable
  • Veterans with impairment that would not allow them to engage in study activities including active psychosis, cognitive deficits, severe substance use requiring detoxification (documented in electronic health record or reported by a primary care clinician team member)

Aim 2 (Randomized controlled trial of PSP compared to TR)

Inclusion:

  • Veteran status (non-Veterans will not be enrolled in this trial)
  • Identifies as a woman or as gender fluid
  • Resides in a rural or highly rural area
  • Veteran must reside in Southeastern Texas, Arkansas or Louisiana
  • Psychological distress in the past 6 months as evidenced by a diagnosis in the electronic health record or elevated score on the PHQ-9, GAD-7 and/or PCL
  • At least one social need in the past 6 months on the PRAPARE
  • Ability to communicate in English including reading, writing, hearing, and speaking well enough to complete research and intervention tasks.

Exclusion:

  • Any Veteran with high suicide or homicide risk and/or evaluated by the PI or another clinician to be clinically unstable
  • Veterans with impairment that would not allow them to engage in study activities including active psychosis, cognitive deficits, severe substance use requiring detoxification (documented in EMR or reported by a PACT member)
  • Veterans who have current VA or non-VA peer support engagement (an appointment within the last month and/or additional follow-up scheduled)

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie podtrzymujące
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Pojedynczy

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: Personalized Support for Progress (PSP)
PSP includes an initial 60-minute video or phone appointment and then follow-up tailored to the Veteran's preferences. The Peer Specialist guides the Veteran through a card-sorting task to prioritize concerns and then create a personalized care plan. The Peer then provides up to six months of outreach and support to implement the care plan. At the end of the six months, the Veteran and peer review the plan, determine next steps and consider other supports and resources to sustain progress made.
Inny: Personalized Support for Progress (PSP)
Personalized Support for Progress (PSP) is a Peer Specialist delivered intervention in which a peer supports Veterans in prioritizing their needs and attaining access to the Veterans' preferred services.
Aktywny komparator: Tailored Referral (TR)
The Tailored Referral (TR) comparator will be comprised of written or emailed information describing resources and contact information for VHA and local social and mental health resources. Examples include information about the appropriate office/person to reach within the local VA or area, help scheduling an appointment, or information for a same-day Primary Care - Mental Health Integration (PCMHI) assessment.
Inny: Tailored Referral (TR)
TR consists of detailed resource information and referral, consistent with standard practice.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Change in actual engagement with social resource services and mental health treatment
Ramy czasowe: Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
VHA Administrative data will be used to assess face-to-face and digital visits (encounters) along with self-reported number of visits on the Epidemiological Catchment Area Survey (ECA).
Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Change in perceived access to social resource services and mental health treatment
Ramy czasowe: Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
The Assessment of Perceived Access to Care (APAC) measure will be used to assess perceived access to social resource services and mental health treatment at each time-point with a scale of 1-5 so that higher total scores equals better access.
Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Veteran satisfaction
Ramy czasowe: 6 Months (post-intervention) and 9 Months (3 Months post-intervention)
Veteran satisfaction will be measures using the Client Satisfaction Questionnaire-8 (CSQ-8), an 8 item measure of participant satisfaction with services. An overall score is calculated by summing the respondent's rating (item rating) score for each scale item. For the CSQ-8 scores range from 8 to 32, with higher values indicating higher satisfaction.
6 Months (post-intervention) and 9 Months (3 Months post-intervention)
Change in depression symptoms
Ramy czasowe: Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Change in depression symptoms for Veteran participants will be assessed using the Patient Health Questionnaire (PHQ)-9, a self-administered depression scale. The total score can range from 1 to 27 with a higher score indicating more severe depression.
Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Change in social needs
Ramy czasowe: Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Change in social needs will be assessed using the Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences (PRAPARE), a standardized tool for collecting social determinants of health (SDH) data including socioeconomic and psychosocial characteristics. The total score can range from 0 to 22 with the total cumulative score indicating presence of risk and unmet needs.
Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Change in greater perceived progress on needs
Ramy czasowe: Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
An adapted version of the Goal Attainment Scale (GAS) will be used to assess Veteran perceived progress on needs. The GAS is a functional scale used to measure the extent of progress towards individual goals during the course of an intervention. Each subject has their own outcome measures but they are scored in a standardized way. Scale items are based on current and expected levels of performance.
Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Change in functioning
Ramy czasowe: Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
The Brief Inventory of Psychosocial Functioning (B-IPF) will be used to measure change in functioning. The B-IPF is an 7-item self-report instrument measuring PTSD-related functional impairment in the past 30 days by looking at seven functional domains including romantic relationships, family relationships, work, friendships and socializing, parenting, education, and self-care. Items are scored on a Likert scale from 0 to 6. The B-IPF is scored by summing the scored items to create a total score, dividing the total score by the maximum possible score based on the number of items scored, and multiplying by 100. The B-IPF represents an overall index of functioning, with higher scores indicating greater functional impairment.
Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Change in Perception of Quality of Life
Ramy czasowe: Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
The World Health Organization Quality of Life (WHO-QOL) measure will be used to assess quality of life (QOL) for each participant in the context of culture, value systems, personal goals, standards and concerns. The scale is scored between 0 to 100 with higher scores indicating a higher quality of life.
Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Stigma-related beliefs about mental health
Ramy czasowe: Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
The Endorsed and Anticipated Stigma Inventory (EASI) is a tool for assessing beliefs about mental illness and mental health treatment among Veterans. The scales are scored so that higher scores are indicative of greater stigma.
Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Change in perceived stress
Ramy czasowe: Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
The Perceived Stress Scale (PSS) will be used to measure each participants subjective understanding of their psychological stress level in the past month. Scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress.
Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Change in anxiety symptoms
Ramy czasowe: Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Change in anxiety symptoms for Veteran participants will be assessed using the Generalized Anxiety Disorder (GAD)-7, a seven-item instrument used to measure the severity of generalized anxiety disorder (GAD). The total score can range from 0 to 21 with a higher score indicating a larger amount of anxiety symptoms.
Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Change in Post-Traumatic Stress Disorder (PTSD) symptoms
Ramy czasowe: Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Change in PTSD symptoms for Veteran participants will be assessed using the Post Traumatic Stress Disorder (PTSD) Checklist (PCL-5), a 20-item self-report measure that assesses the 20 Diagnostic and Statistical Manual-5 symptoms of PTSD. For this trial a score of 31 or higher indicates a positive screen for PTSD.
Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)

Inne miary wyników

Miara wyniku
Opis środka
Ramy czasowe
Therapeutic alliance
Ramy czasowe: Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
The Kim Alliance Scale (KAS-R) will be used to assess the quality of the therapeutic alliance between the Veteran and provider along with patient empowerment and satisfaction with the relationship.
Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Perceived Confidence
Ramy czasowe: Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
The Perceived Confidence Scale will be used to assess each participants' feelings of confidence in engaging in tasks independently.
Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
Autonomy Support
Ramy czasowe: Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)
The Autonomy Support Questionnaire will be used to assess each participants perceptions of autonomy support from their provider or peer.
Baseline, 6 Months (post-intervention), and 9 Months (3 Months post-intervention)

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Sponsor

Syracuse VA Medical Center

Współpracownicy

US Department of Veterans Affairs

Śledczy

  • Główny śledczy: Ellen Poleshuck, PhD, Syracuse VA Medical Center
  • Główny śledczy: Derrecka Boykin, PhD, Michael E. DeBakey Medical Center

Publikacje i pomocne linki

Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.

Publikacje ogólne

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

1 października 2021

Zakończenie podstawowe (Oczekiwany)

1 stycznia 2024

Ukończenie studiów (Oczekiwany)

1 października 2024

Daty rejestracji na studia

Pierwszy przesłany

6 lipca 2022

Pierwszy przesłany, który spełnia kryteria kontroli jakości

25 lipca 2022

Pierwszy wysłany (Rzeczywisty)

28 lipca 2022

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

28 lipca 2022

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

25 lipca 2022

Ostatnia weryfikacja

1 lipca 2022

Więcej informacji

Terminy związane z tym badaniem

Słowa kluczowe

Dodatkowe istotne warunki MeSH

Inne numery identyfikacyjne badania

  • H-50334
  • 1652536 (Inny identyfikator: Syracuse VA Medical Center IRB)

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

TAk

Opis planu IPD

Once all data collection is complete and the coded database is finalized, individual participant data (IPD) will be shared according to PI discretion. For instance, IPD may be shared to be used in meta-analyses or other review papers. No identifiable participant information will be shared.

Ramy czasowe udostępniania IPD

The data will be available once the database is finalized and will remain available in the future.

Kryteria dostępu do udostępniania IPD

Access to the data can be obtained by emailing the PIs and describing the reason the data is needed.

Typ informacji pomocniczych dotyczących udostępniania IPD

  • Protokół badania
  • Plan analizy statystycznej (SAP)
  • Raport z badania klinicznego (CSR)
  • Kod analityczny

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Badania kliniczne na Personalized Support for Progress (PSP)

Wyszukaj podobne próby

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

CROs by country

CROs in Indonesia

Warunki

Rzadkie choroby

Interwencje lekowe

Suplementy diety

Sponsor / Współpracownicy

Lokalizacje

Subskrybuj